Facebook
Twitter
Pinterest
Instagram
Google+
YouTube
LinkedIn
RSS
In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster weight loss drug, opening the door for cheaper competing versions.
Facebook
Twitter
Pinterest
Instagram
Google+
YouTube
LinkedIn
RSS